

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | * positive regulation by organism of defense response of other organism involved in symbiotic interact | 6.06772381 |
| 2 | * modulation by symbiont of host immune response (GO:0052553) | 6.06772381 |
| 3 | * positive regulation by symbiont of host defense response (GO:0052509) | 6.06772381 |
| 4 | * modulation by symbiont of host defense response (GO:0052031) | 6.06772381 |
| 5 | * modulation by organism of immune response of other organism involved in symbiotic interaction (GO:00 | 6.06772381 |
| 6 | * modulation by organism of defense response of other organism involved in symbiotic interaction (GO:0 | 6.06772381 |
| 7 | negative regulation of cell killing (GO:0031342) | 5.60544338 |
| 8 | negative regulation of leukocyte mediated cytotoxicity (GO:0001911) | 5.60544338 |
| 9 | * response to peptidoglycan (GO:0032494) | 5.18020756 |
| 10 | * detection of other organism (GO:0098543) | 4.76820990 |
| 11 | neutrophil activation involved in immune response (GO:0002283) | 4.62461319 |
| 12 | * response to host immune response (GO:0052572) | 4.52610911 |
| 13 | * response to immune response of other organism involved in symbiotic interaction (GO:0052564) | 4.52610911 |
| 14 | positive regulation of interferon-alpha production (GO:0032727) | 4.39346422 |
| 15 | * detection of bacterium (GO:0016045) | 4.38383839 |
| 16 | superoxide anion generation (GO:0042554) | 4.35962542 |
| 17 | NIK/NF-kappaB signaling (GO:0038061) | 4.31644944 |
| 18 | * macrophage activation involved in immune response (GO:0002281) | 4.24111516 |
| 19 | regulation of interferon-alpha production (GO:0032647) | 4.22513185 |
| 20 | * detection of external biotic stimulus (GO:0098581) | 4.19576639 |
| 21 | regulation of interferon-beta biosynthetic process (GO:0045357) | 4.17998629 |
| 22 | * response to host (GO:0075136) | 4.12763796 |
| 23 | * response to host defenses (GO:0052200) | 4.12763796 |
| 24 | * response to defenses of other organism involved in symbiotic interaction (GO:0052173) | 4.12763796 |
| 25 | antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-independent (G | 4.12546269 |
| 26 | * response to muramyl dipeptide (GO:0032495) | 4.07506085 |
| 27 | positive regulation of heat generation (GO:0031652) | 4.07104387 |
| 28 | positive regulation of chemokine biosynthetic process (GO:0045080) | 4.06042832 |
| 29 | type I interferon signaling pathway (GO:0060337) | 3.95348990 |
| 30 | cellular response to type I interferon (GO:0071357) | 3.95348990 |
| 31 | immunoglobulin mediated immune response (GO:0016064) | 3.94649894 |
| 32 | response to type I interferon (GO:0034340) | 3.92946919 |
| 33 | lipopolysaccharide-mediated signaling pathway (GO:0031663) | 3.90946805 |
| 34 | granulocyte activation (GO:0036230) | 3.83089480 |
| 35 | neutrophil activation (GO:0042119) | 3.82018830 |
| 36 | respiratory burst (GO:0045730) | 3.78603852 |
| 37 | I-kappaB phosphorylation (GO:0007252) | 3.78240096 |
| 38 | positive regulation of antigen receptor-mediated signaling pathway (GO:0050857) | 3.77943228 |
| 39 | hydrogen peroxide biosynthetic process (GO:0050665) | 3.69848122 |
| 40 | regulation of fever generation (GO:0031620) | 3.69111237 |
| 41 | interferon-gamma-mediated signaling pathway (GO:0060333) | 3.65438798 |
| 42 | * regulation of gamma-delta T cell activation (GO:0046643) | 3.64344151 |
| 43 | positive regulation of toll-like receptor signaling pathway (GO:0034123) | 3.62994793 |
| 44 | * positive regulation of cellular amide metabolic process (GO:0034250) | 3.59520845 |
| 45 | leukocyte aggregation (GO:0070486) | 3.58606728 |
| 46 | neutrophil mediated immunity (GO:0002446) | 3.58296476 |
| 47 | germinal center formation (GO:0002467) | 3.57482911 |
| 48 | * negative regulation of lymphocyte mediated immunity (GO:0002707) | 3.54419006 |
| 49 | positive regulation of interferon-beta production (GO:0032728) | 3.51300819 |
| 50 | regulation of tumor necrosis factor biosynthetic process (GO:0042534) | 3.50785834 |
| 51 | positive regulation of interleukin-8 biosynthetic process (GO:0045416) | 3.50576105 |
| 52 | regulation of chemokine biosynthetic process (GO:0045073) | 3.46804512 |
| 53 | regulation of T cell tolerance induction (GO:0002664) | 3.46047211 |
| 54 | production of molecular mediator involved in inflammatory response (GO:0002532) | 3.45170887 |
| 55 | regulation of tolerance induction (GO:0002643) | 3.43111463 |
| 56 | positive regulation of mast cell degranulation (GO:0043306) | 3.39803995 |
| 57 | positive regulation of mast cell activation involved in immune response (GO:0033008) | 3.39803995 |
| 58 | negative regulation of viral genome replication (GO:0045071) | 3.36133638 |
| 59 | response to protozoan (GO:0001562) | 3.35183094 |
| 60 | * positive regulation of gamma-delta T cell activation (GO:0046645) | 3.33849834 |
| 61 | regulation of T-helper 2 cell differentiation (GO:0045628) | 3.32295896 |
| 62 | regulation of mast cell degranulation (GO:0043304) | 3.29516023 |
| 63 | B cell receptor signaling pathway (GO:0050853) | 3.29189227 |
| 64 | leukocyte migration involved in inflammatory response (GO:0002523) | 3.27627522 |
| 65 | regulation of interleukin-12 biosynthetic process (GO:0045075) | 3.27380932 |
| 66 | reactive oxygen species biosynthetic process (GO:1903409) | 3.26903165 |
| 67 | positive regulation of interleukin-2 biosynthetic process (GO:0045086) | 3.26589561 |
| 68 | regulation of heat generation (GO:0031650) | 3.24790303 |
| 69 | modulation by symbiont of host cellular process (GO:0044068) | 3.22365441 |
| 70 | response to interleukin-15 (GO:0070672) | 3.20925820 |
| 71 | regulation of gamma-delta T cell differentiation (GO:0045586) | 3.20489121 |
| 72 | positive regulation of granulocyte macrophage colony-stimulating factor production (GO:0032725) | 3.20155604 |
| 73 | antigen processing and presentation of endogenous antigen (GO:0019883) | 3.19927246 |
| 74 | regulation of syncytium formation by plasma membrane fusion (GO:0060142) | 3.19898359 |
| 75 | positive regulation of mast cell activation (GO:0033005) | 3.19232482 |
| 76 | * negative regulation of leukocyte mediated immunity (GO:0002704) | 3.18150242 |
| 77 | negative regulation of cytokine production involved in immune response (GO:0002719) | 3.15224686 |
| 78 | * microglial cell activation (GO:0001774) | 3.14688920 |
| 79 | negative regulation of erythrocyte differentiation (GO:0045647) | 3.14157168 |
| 80 | regulation of mast cell activation involved in immune response (GO:0033006) | 3.12580661 |
| 81 | antigen processing and presentation of endogenous peptide antigen via MHC class I (GO:0019885) | 3.11205025 |
| 82 | antigen processing and presentation of endogenous peptide antigen (GO:0002483) | 3.11205025 |
| 83 | * detection of molecule of bacterial origin (GO:0032490) | 3.10493712 |
| 84 | antigen processing and presentation via MHC class Ib (GO:0002475) | 3.09596453 |
| 85 | regulation of leukocyte degranulation (GO:0043300) | 3.08774208 |
| 86 | regulation of granulocyte macrophage colony-stimulating factor production (GO:0032645) | 3.08402518 |
| 87 | positive regulation of NF-kappaB import into nucleus (GO:0042346) | 3.07851308 |
| 88 | * negative regulation of interleukin-12 production (GO:0032695) | 3.07406898 |
| 89 | cytokine secretion (GO:0050663) | 3.07400507 |
| 90 | regulation of mast cell activation (GO:0033003) | 3.07164332 |
| 91 | regulation of B cell receptor signaling pathway (GO:0050855) | 3.05965941 |
| 92 | * negative regulation of T cell mediated immunity (GO:0002710) | 3.04719127 |
| 93 | regulation of T-helper 1 cell differentiation (GO:0045625) | 3.04560669 |
| 94 | * macrophage activation (GO:0042116) | 3.02734846 |
| 95 | regulation of interleukin-8 biosynthetic process (GO:0045414) | 3.01839506 |
| 96 | natural killer cell mediated cytotoxicity (GO:0042267) | 3.01088510 |
| 97 | natural killer cell mediated immunity (GO:0002228) | 3.01088510 |
| 98 | positive regulation of B cell differentiation (GO:0045579) | 3.01037431 |
| 99 | negative regulation of CD4-positive, alpha-beta T cell activation (GO:2000515) | 3.00466168 |
| 100 | * positive regulation of interleukin-12 production (GO:0032735) | 2.99937263 |
| 101 | negative regulation of mast cell activation (GO:0033004) | 2.99881034 |
| 102 | * positive regulation of nitric-oxide synthase biosynthetic process (GO:0051770) | 2.98152852 |
| 103 | response to interferon-alpha (GO:0035455) | 2.97966282 |
| 104 | positive regulation of interferon-gamma biosynthetic process (GO:0045078) | 2.96634832 |
| 105 | T-helper 1 type immune response (GO:0042088) | 2.96615459 |
| 106 | * myeloid cell activation involved in immune response (GO:0002275) | 2.96277804 |
| 107 | negative regulation of interleukin-6 production (GO:0032715) | 2.96150221 |
| 108 | T cell migration (GO:0072678) | 2.96143245 |
| 109 | positive regulation of syncytium formation by plasma membrane fusion (GO:0060143) | 2.96093181 |
| 110 | positive regulation of chemokine production (GO:0032722) | 2.92932018 |
| 111 | negative regulation of innate immune response (GO:0045824) | 2.92000618 |
| 112 | cellular extravasation (GO:0045123) | 2.91355754 |
| 113 | positive regulation of tolerance induction (GO:0002645) | 2.91247815 |
| 114 | leukocyte degranulation (GO:0043299) | 2.91119602 |
| 115 | tolerance induction (GO:0002507) | 2.91118964 |
| 116 | positive regulation of tumor necrosis factor biosynthetic process (GO:0042535) | 2.90713575 |
| 117 | cellular response to interleukin-15 (GO:0071350) | 2.90474009 |
| 118 | regulation of B cell differentiation (GO:0045577) | 2.89881820 |
| 119 | * myeloid leukocyte activation (GO:0002274) | 2.88271294 |
| 120 | defense response to protozoan (GO:0042832) | 2.85845319 |
| 121 | leukocyte mediated cytotoxicity (GO:0001909) | 2.85655986 |
| 122 | negative regulation of interleukin-17 production (GO:0032700) | 2.83435229 |
| 123 | positive regulation of myeloid leukocyte mediated immunity (GO:0002888) | 2.83225477 |
| 124 | negative thymic T cell selection (GO:0045060) | 2.82881259 |
| 125 | positive regulation of heterotypic cell-cell adhesion (GO:0034116) | 2.82407532 |
| 126 | B cell mediated immunity (GO:0019724) | 2.80205349 |
| 127 | regulation of mononuclear cell migration (GO:0071675) | 2.77277063 |
| 128 | regulation of alpha-beta T cell proliferation (GO:0046640) | 2.76967007 |
| 129 | * positive regulation of antigen processing and presentation (GO:0002579) | 2.76711073 |
| 130 | regulation of RIG-I signaling pathway (GO:0039535) | 2.75809688 |
| 131 | * detection of biotic stimulus (GO:0009595) | 2.75451926 |
| 132 | regulation of integrin activation (GO:0033623) | 2.75107543 |
| 133 | regulation of podosome assembly (GO:0071801) | 2.74659990 |
| 134 | regulation of myeloid leukocyte mediated immunity (GO:0002886) | 2.74309172 |
| 135 | myeloid leukocyte mediated immunity (GO:0002444) | 2.72608030 |
| 136 | adaptive immune response based on somatic recombination of immune receptors built from immunoglobuli | 2.70799869 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 6.55038025 |
| 2 | IRF8_21731497_ChIP-ChIP_J774_Mouse | 6.43588632 |
| 3 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 4.69455399 |
| 4 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 4.33638293 |
| 5 | IRF8_22096565_ChIP-ChIP_GC-B_Mouse | 4.04842344 |
| 6 | * IRF8_27001747_Chip-Seq_BMDM_Mouse | 4.02758925 |
| 7 | FOXP3_17237761_ChIP-ChIP_TREG_Mouse | 4.00102645 |
| 8 | * SMRT_22465074_ChIP-Seq_MACROPHAGES_Mouse | 3.84556634 |
| 9 | Nerf2_26677805_Chip-Seq_MACROPHAGESS_Mouse | 3.47224888 |
| 10 | STAT6_20620947_ChIP-Seq_CD4_POS_T_Human | 3.42149216 |
| 11 | NCOR_22465074_ChIP-Seq_MACROPHAGES_Mouse | 3.12980647 |
| 12 | TP63_17297297_ChIP-ChIP_HaCaT_Human | 2.92148725 |
| 13 | * RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 2.85864042 |
| 14 | MECOM_23826213_ChIP-Seq_KASUMI_Mouse | 2.82802356 |
| 15 | STAT3_20064451_ChIP-Seq_CD4+T_Mouse | 2.81174559 |
| 16 | SMAD_19615063_ChIP-ChIP_OVARY_Human | 2.63742216 |
| 17 | EGR1_19374776_ChIP-ChIP_THP-1_Human | 2.57289372 |
| 18 | MYB_21317192_ChIP-Seq_ERMYB_Mouse | 2.48525238 |
| 19 | STAT4_19710469_ChIP-ChIP_TH1__Mouse | 2.28686853 |
| 20 | SPI1_22096565_ChIP-ChIP_GC-B_Mouse | 2.22101640 |
| 21 | MYC_22102868_ChIP-Seq_BL_Human | 2.06974518 |
| 22 | VDR_23401126_ChIP-Seq_LCL-AND-THP1_Human | 1.96366415 |
| 23 | SCL_19346495_ChIP-Seq_HPC-7_Human | 1.93827436 |
| 24 | UTX_26944678_Chip-Seq_JUKART_Human | 1.86961606 |
| 25 | * PPARG_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.84561061 |
| 26 | TCF7_22412390_ChIP-Seq_EML_Mouse | 1.81765195 |
| 27 | KDM2B_26808549_Chip-Seq_SUP-B15_Human | 1.79904861 |
| 28 | VDR_24787735_ChIP-Seq_THP-1_Human | 1.79321659 |
| 29 | GATA1_22025678_ChIP-Seq_K562_Human | 1.78904138 |
| 30 | RUNX_20019798_ChIP-Seq_JUKART_Human | 1.77765259 |
| 31 | * PPARG_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.75377453 |
| 32 | GATA2_21666600_ChIP-Seq_HMVEC_Human | 1.69710928 |
| 33 | BRD4_27068464_Chip-Seq_AML-cells_Mouse | 1.69308332 |
| 34 | SPI1_23547873_ChIP-Seq_NB4_Human | 1.63875185 |
| 35 | PU_27001747_Chip-Seq_BMDM_Mouse | 1.63380036 |
| 36 | * STAT5_23275557_ChIP-Seq_MAMMARY-EPITHELIUM_Mouse | 1.61811254 |
| 37 | CIITA_18437201_ChIP-ChIP_Raji_B_and_iDC_Human | 1.57588176 |
| 38 | * MAF_26560356_Chip-Seq_TH2_Human | 1.55107216 |
| 39 | KDM2B_26808549_Chip-Seq_DND41_Human | 1.53333555 |
| 40 | TAL1_20566737_ChIP-Seq_PRIMARY_FETAL_LIVER_ERYTHROID_Mouse | 1.48794606 |
| 41 | FOXO1_25302145_ChIP-Seq_T-LYMPHOCYTE_Mouse | 1.47873990 |
| 42 | KDM2B_26808549_Chip-Seq_SIL-ALL_Human | 1.47702789 |
| 43 | * SPI1_23127762_ChIP-Seq_K562_Human | 1.46354461 |
| 44 | NUCKS1_24931609_ChIP-Seq_HEPATOCYTES_Mouse | 1.42792557 |
| 45 | KDM2B_26808549_Chip-Seq_HPB-ALL_Human | 1.40161021 |
| 46 | STAT3_22323479_ChIP-Seq_MACROPHAGE_Mouse | 1.37776569 |
| 47 | * CEBPB_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.35659395 |
| 48 | MYB_26560356_Chip-Seq_TH2_Human | 1.33034475 |
| 49 | MEIS1_20887958_ChIP-Seq_HPC-7_Mouse | 1.31609400 |
| 50 | TRP63_18441228_ChIP-ChIP_KERATINOCYTES_Mouse | 1.30449916 |
| 51 | RUNX1_20887958_ChIP-Seq_HPC-7_Mouse | 1.24361935 |
| 52 | * CEBPB_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.23573636 |
| 53 | VDR_24763502_ChIP-Seq_THP-1_Human | 1.22952530 |
| 54 | ELK3_25401928_ChIP-Seq_HUVEC_Human | 1.21036101 |
| 55 | RUNX1_22412390_ChIP-Seq_EML_Mouse | 1.16667140 |
| 56 | LMO2_20887958_ChIP-Seq_HPC-7_Mouse | 1.12073259 |
| 57 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 1.11075836 |
| 58 | GATA1_22383799_ChIP-Seq_G1ME_Mouse | 1.10569365 |
| 59 | GATA1_19941826_ChIP-Seq_K562_Human | 1.10449047 |
| 60 | ASXL1_24218140_ChIP-Seq_BMDM_Mouse | 1.09766146 |
| 61 | MAF_26560356_Chip-Seq_TH1_Human | 1.09548959 |
| 62 | NFE2L2_22581777_ChIP-Seq_LYMPHOBLASTOID_Human | 1.08341101 |
| 63 | VDR_20736230_ChIP-Seq_LYMPHOBLASTOID_Human | 1.07661860 |
| 64 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 1.07231201 |
| 65 | LYL1_20887958_ChIP-Seq_HPC-7_Mouse | 1.07105436 |
| 66 | GATA1_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 1.07073560 |
| 67 | GATA2_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 1.06467031 |
| 68 | CDX2_19796622_ChIP-Seq_MESCs_Mouse | 1.05574622 |
| 69 | LXR_22292898_ChIP-Seq_THP-1_Human | 1.03083361 |
| 70 | KDM2B_26808549_Chip-Seq_JURKAT_Human | 1.02760404 |
| 71 | GATA3_26560356_Chip-Seq_TH2_Human | 1.02631672 |
| 72 | STAT6_21828071_ChIP-Seq_BEAS2B_Human | 1.02365479 |
| 73 | MYB_26560356_Chip-Seq_TH1_Human | 1.02300014 |
| 74 | TAL1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 1.00808592 |
| 75 | PU.1_20513432_ChIP-Seq_Bcells_Mouse | 1.00577976 |
| 76 | BCL11B_21912641_ChIP-Seq_STHDH_STRIUM_Mouse | 1.00160098 |
| 77 | * PU.1_20176806_ChIP-Seq_MACROPHAGES_Mouse | 0.99244511 |
| 78 | ESR1_21235772_ChIP-Seq_MCF-7_Human | 0.98124008 |
| 79 | SFPI1_20887958_ChIP-Seq_HPC-7_Mouse | 0.96461594 |
| 80 | IKZF1_21737484_ChIP-ChIP_HCT116_Human | 0.96278849 |
| 81 | * SPI1_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 0.95008399 |
| 82 | PCGF2_27294783_Chip-Seq_NPCs_Mouse | 0.94074172 |
| 83 | * CEBPB_20513432_ChIP-Seq_MACROPHAGES_Mouse | 0.92503464 |
| 84 | GATA3_27048872_Chip-Seq_THYMUS_Human | 0.92448933 |
| 85 | CHD7_19251738_ChIP-ChIP_MESCs_Mouse | 0.92265059 |
| 86 | E2A_27217539_Chip-Seq_RAMOS-Cell_line_Human | 0.91486637 |
| 87 | FLI1_20887958_ChIP-Seq_HPC-7_Mouse | 0.91428794 |
| 88 | * CEBPA_20513432_ChIP-Seq_MACROPHAGES_Mouse | 0.91358605 |
| 89 | SOX9_22984422_ChIP-ChIP_TESTIS_Rat | 0.90787289 |
| 90 | CEBPD_21427703_ChIP-Seq_3T3-L1_Mouse | 0.90498622 |
| 91 | GATA2_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 0.89613428 |
| 92 | SMAD3_18955504_ChIP-ChIP_HaCaT_Human | 0.88676462 |
| 93 | SMAD2_18955504_ChIP-ChIP_HaCaT_Human | 0.88676462 |
| 94 | GATA2_19941826_ChIP-Seq_K562_Human | 0.88214805 |
| 95 | CJUN_26792858_Chip-Seq_BT549_Human | 0.88189397 |
| 96 | NOTCH1_21737748_ChIP-Seq_TLL_Human | 0.87214791 |
| 97 | SUZ12_27294783_Chip-Seq_NPCs_Mouse | 0.85118544 |
| 98 | NFE2_27457419_Chip-Seq_LIVER_Mouse | 0.84100751 |
| 99 | BCL6_27268052_Chip-Seq_Bcells_Human | 0.83078350 |
| 100 | BCOR_27268052_Chip-Seq_Bcells_Human | 0.82728377 |
| 101 | EZH2_27294783_Chip-Seq_NPCs_Mouse | 0.82093902 |
| 102 | PU1_27457419_Chip-Seq_LIVER_Mouse | 0.81476975 |
| 103 | TBP_23326641_ChIP-Seq_C3H10T1-2_Mouse | 0.81266569 |
| 104 | NCOR1_26117541_ChIP-Seq_K562_Human | 0.80506991 |
| 105 | GATA2_22383799_ChIP-Seq_G1ME_Mouse | 0.80341244 |
| 106 | VDR_21846776_ChIP-Seq_THP-1_Human | 0.80037820 |
| 107 | STAT3_18555785_Chip-Seq_ESCs_Mouse | 0.79084866 |
| 108 | CEBPB_21427703_ChIP-Seq_3T3-L1_Mouse | 0.78461995 |
| 109 | CEBPD_23245923_ChIP-Seq_MEFs_Mouse | 0.78153886 |
| 110 | GBX2_23144817_ChIP-Seq_PC3_Human | 0.78094091 |
| 111 | ZFP57_27257070_Chip-Seq_ESCs_Mouse | 0.77783280 |
| 112 | PCGF2_27294783_Chip-Seq_ESCs_Mouse | 0.77652461 |
| 113 | FOXA1_27197147_Chip-Seq_ENDOMETRIOID-ADENOCARCINOMA_Human | 0.76504636 |
| 114 | GATA2_20887958_ChIP-Seq_HPC-7_Mouse | 0.76116227 |
| 115 | SUZ12_18555785_Chip-Seq_ESCs_Mouse | 0.75634148 |
| 116 | * RUNX1_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.75601354 |
| 117 | SCL_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.74185044 |
| 118 | CTNNB1_24651522_ChIP-Seq_LGR5+_INTESTINAL_STEM_Human | 0.73733814 |
| 119 | P53_22387025_ChIP-Seq_ESCs_Mouse | 0.72452724 |
| 120 | * GATA1_19941827_ChIP-Seq_MEL86_Mouse | 0.72391786 |
| 121 | GATA1_19941827_ChIP-Seq_MEL_Mouse | 0.70976147 |
| 122 | EGR1_19032775_ChIP-ChIP_M12_Human | 0.70664895 |
| 123 | NMYC_18555785_Chip-Seq_ESCs_Mouse | 0.69908014 |
| 124 | SPI1_22790984_ChIP-Seq_ERYTHROLEUKEMIA_Mouse | 0.69737325 |
| 125 | RUNX1_17652178_ChIP-ChIP_JURKAT_Human | 0.69665912 |
| 126 | TCF21_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 0.69355393 |
| 127 | SOX2_20726797_ChIP-Seq_SW620_Human | 0.69099285 |
| 128 | EBF1_22473956_ChIP-Seq_BONE_MARROW_Mouse | 0.69013486 |
| 129 | SMRT_27268052_Chip-Seq_Bcells_Human | 0.68426050 |
| 130 | E2F1_18555785_Chip-Seq_ESCs_Mouse | 0.68336235 |
| 131 | * PU.1_20513432_ChIP-Seq_MACROPHAGES_Mouse | 0.68311345 |
| 132 | SPI1_20517297_ChIP-Seq_HL60_Human | 0.67734590 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0001835_abnormal_antigen_presentation | 4.33470290 |
| 2 | MP0003436_decreased_susceptibility_to | 3.70833473 |
| 3 | * MP0009785_altered_susceptibility_to | 3.60827466 |
| 4 | MP0003303_peritoneal_inflammation | 3.55836938 |
| 5 | * MP0002419_abnormal_innate_immunity | 3.20613410 |
| 6 | MP0002148_abnormal_hypersensitivity_rea | 3.20151480 |
| 7 | MP0005000_abnormal_immune_tolerance | 3.08096866 |
| 8 | MP0000569_abnormal_digit_pigmentation | 2.96177189 |
| 9 | * MP0001790_abnormal_immune_system | 2.91548936 |
| 10 | * MP0005387_immune_system_phenotype | 2.91548936 |
| 11 | * MP0005025_abnormal_response_to | 2.88710566 |
| 12 | MP0004510_myositis | 2.85673645 |
| 13 | * MP0002452_abnormal_antigen_presenting | 2.68652642 |
| 14 | MP0003724_increased_susceptibility_to | 2.63605039 |
| 15 | * MP0001800_abnormal_humoral_immune | 2.57725367 |
| 16 | * MP0002723_abnormal_immune_serum | 2.45232416 |
| 17 | MP0009278_abnormal_bone_marrow | 2.44146841 |
| 18 | MP0006082_CNS_inflammation | 2.31233521 |
| 19 | MP0005671_abnormal_response_to | 2.30477510 |
| 20 | MP0002254_reproductive_system_inflammat | 2.27254474 |
| 21 | MP0004947_skin_inflammation | 2.24899463 |
| 22 | * MP0001819_abnormal_immune_cell | 2.23596939 |
| 23 | * MP0000685_abnormal_immune_system | 2.20166629 |
| 24 | * MP0002420_abnormal_adaptive_immunity | 2.19635294 |
| 25 | MP0001533_abnormal_skeleton_physiology | 2.03066507 |
| 26 | MP0009764_decreased_sensitivity_to | 1.96444588 |
| 27 | MP0003191_abnormal_cellular_cholesterol | 1.96334563 |
| 28 | MP0003183_abnormal_peptide_metabolism | 1.92654520 |
| 29 | MP0005464_abnormal_platelet_physiology | 1.92560146 |
| 30 | MP0001853_heart_inflammation | 1.85794374 |
| 31 | MP0002405_respiratory_system_inflammati | 1.84736141 |
| 32 | MP0005174_abnormal_tail_pigmentation | 1.77675539 |
| 33 | MP0003172_abnormal_lysosome_physiology | 1.75706696 |
| 34 | * MP0001845_abnormal_inflammatory_respons | 1.75193690 |
| 35 | MP0005058_abnormal_lysosome_morphology | 1.69583039 |
| 36 | MP0003448_altered_tumor_morphology | 1.67840025 |
| 37 | MP0000015_abnormal_ear_pigmentation | 1.67528773 |
| 38 | * MP0010155_abnormal_intestine_physiology | 1.66620516 |
| 39 | MP0002277_abnormal_respiratory_mucosa | 1.65592495 |
| 40 | MP0002998_abnormal_bone_remodeling | 1.64151733 |
| 41 | MP0000343_altered_response_to | 1.59012241 |
| 42 | * MP0000716_abnormal_immune_system | 1.52362206 |
| 43 | * MP0002398_abnormal_bone_marrow | 1.45629218 |
| 44 | MP0005310_abnormal_salivary_gland | 1.44267852 |
| 45 | MP0002132_abnormal_respiratory_system | 1.44033906 |
| 46 | MP0001545_abnormal_hematopoietic_system | 1.40599874 |
| 47 | MP0005397_hematopoietic_system_phenotyp | 1.40599874 |
| 48 | MP0002006_tumorigenesis | 1.37857194 |
| 49 | * MP0008469_abnormal_protein_level | 1.36545951 |
| 50 | MP0004782_abnormal_surfactant_physiolog | 1.34490293 |
| 51 | MP0003075_altered_response_to | 1.33687057 |
| 52 | MP0000566_synostosis | 1.30423872 |
| 53 | MP0008004_abnormal_stomach_pH | 1.27318634 |
| 54 | MP0004381_abnormal_hair_follicle | 1.25256579 |
| 55 | MP0005390_skeleton_phenotype | 1.23456888 |
| 56 | MP0003453_abnormal_keratinocyte_physiol | 1.21700515 |
| 57 | MP0003866_abnormal_defecation | 1.20814681 |
| 58 | MP0001873_stomach_inflammation | 1.19275183 |
| 59 | MP0009333_abnormal_splenocyte_physiolog | 1.18670591 |
| 60 | MP0000858_altered_metastatic_potential | 1.18026922 |
| 61 | MP0000689_abnormal_spleen_morphology | 1.17183937 |
| 62 | MP0002933_joint_inflammation | 1.17027129 |
| 63 | * MP0002429_abnormal_blood_cell | 1.16909548 |
| 64 | MP0000383_abnormal_hair_follicle | 1.12036538 |
| 65 | MP0003941_abnormal_skin_development | 1.11456747 |
| 66 | MP0003690_abnormal_glial_cell | 1.11288060 |
| 67 | MP0003763_abnormal_thymus_physiology | 1.11013503 |
| 68 | MP0000371_diluted_coat_color | 1.09400732 |
| 69 | MP0005167_abnormal_blood-brain_barrier | 1.09381186 |
| 70 | MP0003300_gastrointestinal_ulcer | 1.08181215 |
| 71 | MP0005257_abnormal_intraocular_pressure | 1.08119109 |
| 72 | MP0001851_eye_inflammation | 1.06467676 |
| 73 | MP0005166_decreased_susceptibility_to | 1.01154180 |
| 74 | MP0003656_abnormal_erythrocyte_physiolo | 0.99732408 |
| 75 | * MP0002722_abnormal_immune_system | 0.99336151 |
| 76 | MP0003828_pulmonary_edema | 0.99036279 |
| 77 | MP0002138_abnormal_hepatobiliary_system | 0.95129017 |
| 78 | MP0002166_altered_tumor_susceptibility | 0.92825090 |
| 79 | MP0005076_abnormal_cell_differentiation | 0.91556306 |
| 80 | MP0000767_abnormal_smooth_muscle | 0.88581381 |
| 81 | MP0005164_abnormal_response_to | 0.85712792 |
| 82 | MP0003045_fibrosis | 0.85149663 |
| 83 | MP0002332_abnormal_exercise_endurance | 0.85136413 |
| 84 | MP0003136_yellow_coat_color | 0.83560864 |
| 85 | MP0000465_gastrointestinal_hemorrhage | 0.81869063 |
| 86 | MP0000490_abnormal_crypts_of | 0.81863735 |
| 87 | MP0001663_abnormal_digestive_system | 0.79968896 |
| 88 | MP0003806_abnormal_nucleotide_metabolis | 0.78563702 |
| 89 | MP0009840_abnormal_foam_cell | 0.77574094 |
| 90 | MP0003091_abnormal_cell_migration | 0.76994885 |
| 91 | MP0001958_emphysema | 0.75552198 |
| 92 | MP0004808_abnormal_hematopoietic_stem | 0.73776194 |
| 93 | MP0003566_abnormal_cell_adhesion | 0.71625317 |
| 94 | * MP0009763_increased_sensitivity_to | 0.71513244 |
| 95 | MP0003795_abnormal_bone_structure | 0.70897577 |
| 96 | MP0001191_abnormal_skin_condition | 0.70674692 |
| 97 | MP0004858_abnormal_nervous_system | 0.70555950 |
| 98 | MP0000604_amyloidosis | 0.70480328 |
| 99 | MP0002396_abnormal_hematopoietic_system | 0.68700451 |
| 100 | MP0005171_absent_coat_pigmentation | 0.66880130 |
| 101 | MP0008874_decreased_physiological_sensi | 0.66332675 |
| 102 | MP0003221_abnormal_cardiomyocyte_apopto | 0.64454888 |
| 103 | MP0001216_abnormal_epidermal_layer | 0.62744158 |
| 104 | MP0002009_preneoplasia | 0.62487803 |
| 105 | MP0005197_abnormal_uvea_morphology | 0.62381338 |
| 106 | MP0005451_abnormal_body_composition | 0.61866289 |
| 107 | * MP0009765_abnormal_xenobiotic_induced | 0.61419557 |
| 108 | MP0009697_abnormal_copulation | 0.60961827 |
| 109 | MP0000249_abnormal_blood_vessel | 0.60123104 |
| 110 | MP0004883_abnormal_blood_vessel | 0.56434748 |
| 111 | * MP0008260_abnormal_autophagy | 0.55864480 |
| 112 | MP0002095_abnormal_skin_pigmentation | 0.55658392 |
| 113 | MP0005075_abnormal_melanosome_morpholog | 0.55197715 |
| 114 | MP0001879_abnormal_lymphatic_vessel | 0.54854844 |
| 115 | MP0000703_abnormal_thymus_morphology | 0.54470438 |
| 116 | MP0005023_abnormal_wound_healing | 0.52501862 |
| 117 | MP0000627_abnormal_mammary_gland | 0.51810679 |
| 118 | MP0000920_abnormal_myelination | 0.49953837 |
| 119 | MP0006054_spinal_hemorrhage | 0.49228912 |
| 120 | MP0000609_abnormal_liver_physiology | 0.46872524 |
| 121 | MP0005319_abnormal_enzyme/_coenzyme | 0.45983416 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Recurrent abscess formation (HP:0002722) | 7.16342056 |
| 2 | Recurrent bacterial skin infections (HP:0005406) | 6.50426693 |
| 3 | Eczematoid dermatitis (HP:0000976) | 6.38003820 |
| 4 | Mediastinal lymphadenopathy (HP:0100721) | 5.32750891 |
| 5 | Recurrent gram-negative bacterial infections (HP:0005420) | 4.94869547 |
| 6 | Stomatitis (HP:0010280) | 4.76404929 |
| 7 | Elevated erythrocyte sedimentation rate (HP:0003565) | 4.52518916 |
| 8 | Gingivitis (HP:0000230) | 4.21615406 |
| 9 | * Abnormality of macrophages (HP:0004311) | 4.16879454 |
| 10 | Prostate neoplasm (HP:0100787) | 4.10160567 |
| 11 | Recurrent skin infections (HP:0001581) | 3.87303221 |
| 12 | Thick nail (HP:0001805) | 3.86325140 |
| 13 | Obstructive lung disease (HP:0006536) | 3.82013393 |
| 14 | Chronic obstructive pulmonary disease (HP:0006510) | 3.82013393 |
| 15 | Recurrent fungal infections (HP:0002841) | 3.71722570 |
| 16 | * Myositis (HP:0100614) | 3.41666649 |
| 17 | Periodontitis (HP:0000704) | 3.37100275 |
| 18 | * Vasculitis (HP:0002633) | 3.32025880 |
| 19 | Spontaneous hematomas (HP:0007420) | 3.31527579 |
| 20 | * Retrobulbar optic neuritis (HP:0100654) | 3.31169956 |
| 21 | * Optic neuritis (HP:0100653) | 3.31169956 |
| 22 | Autoimmune thrombocytopenia (HP:0001973) | 3.29563827 |
| 23 | * Orchitis (HP:0100796) | 3.28425077 |
| 24 | * Encephalitis (HP:0002383) | 3.23449968 |
| 25 | Pustule (HP:0200039) | 3.13267193 |
| 26 | * Keratoconjunctivitis (HP:0001096) | 3.09761231 |
| 27 | Chest pain (HP:0100749) | 3.06220464 |
| 28 | Premature loss of primary teeth (HP:0006323) | 2.97897815 |
| 29 | Recurrent cutaneous fungal infections (HP:0011370) | 2.96583758 |
| 30 | Chronic mucocutaneous candidiasis (HP:0002728) | 2.96583758 |
| 31 | Recurrent viral infections (HP:0004429) | 2.95522310 |
| 32 | T lymphocytopenia (HP:0005403) | 2.88984765 |
| 33 | Recurrent pneumonia (HP:0006532) | 2.88939692 |
| 34 | Increased cerebral lipofuscin (HP:0011813) | 2.88697332 |
| 35 | Episodic fever (HP:0001954) | 2.88347944 |
| 36 | Increased neuronal autofluorescent lipopigment (HP:0002074) | 2.85449739 |
| 37 | Abnormality of T cell number (HP:0011839) | 2.83604981 |
| 38 | Chromosomal breakage induced by crosslinking agents (HP:0003221) | 2.81701690 |
| 39 | Basal ganglia calcification (HP:0002135) | 2.81343615 |
| 40 | Chronic otitis media (HP:0000389) | 2.79795331 |
| 41 | Vacuolated lymphocytes (HP:0001922) | 2.73052629 |
| 42 | * Gangrene (HP:0100758) | 2.70474844 |
| 43 | Urticaria (HP:0001025) | 2.69637202 |
| 44 | * Pulmonary infiltrates (HP:0002113) | 2.66189335 |
| 45 | Gastrointestinal inflammation (HP:0004386) | 2.65823406 |
| 46 | Increased IgM level (HP:0003496) | 2.63890180 |
| 47 | Colitis (HP:0002583) | 2.63775163 |
| 48 | Epistaxis (HP:0000421) | 2.60995729 |
| 49 | Peritonitis (HP:0002586) | 2.59543934 |
| 50 | Tetraparesis (HP:0002273) | 2.57161028 |
| 51 | Osteomyelitis (HP:0002754) | 2.55089447 |
| 52 | * Meningitis (HP:0001287) | 2.53860279 |
| 53 | Hypochromic microcytic anemia (HP:0004840) | 2.52288645 |
| 54 | Cellulitis (HP:0100658) | 2.50023960 |
| 55 | Leukocytosis (HP:0001974) | 2.47981751 |
| 56 | Hypochromic anemia (HP:0001931) | 2.46683092 |
| 57 | Petechiae (HP:0000967) | 2.46421346 |
| 58 | Albinism (HP:0001022) | 2.46032307 |
| 59 | Abnormality of T cells (HP:0002843) | 2.43936029 |
| 60 | Absent frontal sinuses (HP:0002688) | 2.42877789 |
| 61 | Pulmonary artery stenosis (HP:0004415) | 2.40017476 |
| 62 | Stomach cancer (HP:0012126) | 2.37584753 |
| 63 | Parkinsonism with favorable response to dopaminergic medication (HP:0002548) | 2.37530618 |
| 64 | * Anorexia (HP:0002039) | 2.35088612 |
| 65 | * Pulmonary embolism (HP:0002204) | 2.34628325 |
| 66 | Lymphopenia (HP:0001888) | 2.33802229 |
| 67 | Recurrent lower respiratory tract infections (HP:0002783) | 2.32633604 |
| 68 | Panhypogammaglobulinemia (HP:0003139) | 2.32241322 |
| 69 | Chromsome breakage (HP:0040012) | 2.28354984 |
| 70 | * Abnormality of the pleura (HP:0002103) | 2.27876877 |
| 71 | Systemic lupus erythematosus (HP:0002725) | 2.27277748 |
| 72 | Abnormality of the peritoneum (HP:0002585) | 2.23958009 |
| 73 | Purpura (HP:0000979) | 2.23693230 |
| 74 | Increased serum ferritin (HP:0003281) | 2.22469109 |
| 75 | Cheilitis (HP:0100825) | 2.22378313 |
| 76 | Abnormality of cells of the lymphoid lineage (HP:0012140) | 2.22184509 |
| 77 | Autoimmune hemolytic anemia (HP:0001890) | 2.21479071 |
| 78 | Increased IgE level (HP:0003212) | 2.20764113 |
| 79 | Bone pain (HP:0002653) | 2.19755843 |
| 80 | Abnormality of the prostate (HP:0008775) | 2.19681887 |
| 81 | Gingival bleeding (HP:0000225) | 2.18716372 |
| 82 | Submucous cleft hard palate (HP:0000176) | 2.17123376 |
| 83 | Dysostosis multiplex (HP:0000943) | 2.15594949 |
| 84 | Abnormality of T cell physiology (HP:0011840) | 2.14994907 |
| 85 | Eosinophilia (HP:0001880) | 2.14858964 |
| 86 | Abnormality of liposaccharide metabolism (HP:0010968) | 2.13338728 |
| 87 | Abnormality of glycosphingolipid metabolism (HP:0004343) | 2.13338728 |
| 88 | Abnormality of glycolipid metabolism (HP:0010969) | 2.13338728 |
| 89 | Abnormal delayed hypersensitivity skin test (HP:0002963) | 2.08817516 |
| 90 | Clubbing of toes (HP:0100760) | 2.07991760 |
| 91 | Agammaglobulinemia (HP:0004432) | 2.07695748 |
| 92 | Myocardial infarction (HP:0001658) | 2.06659328 |
| 93 | Abnormality of primary teeth (HP:0006481) | 2.05621637 |
| 94 | Parakeratosis (HP:0001036) | 2.02982736 |
| 95 | Amaurosis fugax (HP:0100576) | 2.02658862 |
| 96 | Interstitial pulmonary disease (HP:0006530) | 2.00267786 |
| 97 | * Vertigo (HP:0002321) | 1.98088902 |
| 98 | Porencephaly (HP:0002132) | 1.98079660 |
| 99 | Abnormality of iron homeostasis (HP:0011031) | 1.97272416 |
| 100 | Acute hepatic failure (HP:0006554) | 1.95425562 |
| 101 | Slow saccadic eye movements (HP:0000514) | 1.94757008 |
| 102 | * Abnormality of the endocardium (HP:0004306) | 1.93718497 |
| 103 | Osteolytic defects of the phalanges of the hand (HP:0009771) | 1.91566605 |
| 104 | Osteolytic defects of the hand bones (HP:0009699) | 1.91566605 |
| 105 | * Polyneuropathy (HP:0001271) | 1.91452833 |
| 106 | Hepatosplenomegaly (HP:0001433) | 1.91353393 |
| 107 | Hypergammaglobulinemia (HP:0010702) | 1.90333484 |
| 108 | Alveolar cell carcinoma (HP:0006519) | 1.90306191 |
| 109 | Loss of speech (HP:0002371) | 1.88680883 |
| 110 | Abnormality of the nasal septum (HP:0000419) | 1.88267642 |
| 111 | * Skin ulcer (HP:0200042) | 1.87193018 |
| 112 | Emphysema (HP:0002097) | 1.86494082 |
| 113 | Gastrointestinal stroma tumor (HP:0100723) | 1.86418023 |
| 114 | Granulocytopenia (HP:0001913) | 1.84243858 |
| 115 | Sepsis (HP:0100806) | 1.83249293 |
| 116 | Leukopenia (HP:0001882) | 1.83242258 |
| 117 | Inflammation of the large intestine (HP:0002037) | 1.81655515 |
| 118 | Hematochezia (HP:0002573) | 1.81599757 |
| 119 | * Hemoptysis (HP:0002105) | 1.79431962 |
| 120 | Progressive visual loss (HP:0000529) | 1.77510880 |
| 121 | Amyloidosis (HP:0011034) | 1.76956046 |
| 122 | * Arterial thrombosis (HP:0004420) | 1.76311717 |
| 123 | IgM deficiency (HP:0002850) | 1.76122782 |
| 124 | Prolonged bleeding time (HP:0003010) | 1.75926326 |
| 125 | Plantar hyperkeratosis (HP:0007556) | 1.75492338 |
| 126 | Joint hemorrhage (HP:0005261) | 1.74680503 |
| 127 | Aplasia/Hypoplasia of the frontal sinuses (HP:0009119) | 1.73687082 |
| 128 | Recurrent bronchitis (HP:0002837) | 1.73084348 |
| 129 | Abnormality of the frontal sinuses (HP:0002687) | 1.73008019 |
| 130 | Aplasia cutis congenita (HP:0001057) | 1.72016602 |
| 131 | Axonal loss (HP:0003447) | 1.71027180 |
| 132 | Restrictive lung disease (HP:0002091) | 1.70740954 |
| 133 | Chronic sinusitis (HP:0011109) | 1.70434028 |
| 134 | Gastrointestinal infarctions (HP:0005244) | 1.69547221 |
| 135 | Disinhibition (HP:0000734) | 1.69430833 |
| 136 | * Arthralgia (HP:0002829) | 1.67699605 |
| 137 | * Keratoconjunctivitis sicca (HP:0001097) | 1.67052042 |
| 138 | Spinal cord lesions (HP:0100561) | 1.65492568 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MAP3K14 | 4.88158512 |
| 2 | IRAK3 | 4.57702136 |
| 3 | IRAK4 | 3.56772258 |
| 4 | RIPK4 | 3.54916965 |
| 5 | IKBKE | 3.40850296 |
| 6 | TYK2 | 3.28965737 |
| 7 | TBK1 | 3.15055169 |
| 8 | TXK | 3.11327685 |
| 9 | JAK3 | 2.77368687 |
| 10 | IKBKB | 2.52609868 |
| 11 | MAP4K1 | 2.48942337 |
| 12 | BLK | 2.45917130 |
| 13 | KIT | 2.02907260 |
| 14 | JAK1 | 1.95272745 |
| 15 | CHUK | 1.90903622 |
| 16 | ZAK | 1.81475279 |
| 17 | SIK3 | 1.81134112 |
| 18 | EIF2AK2 | 1.66980906 |
| 19 | TAOK1 | 1.64450620 |
| 20 | GRK6 | 1.62882070 |
| 21 | MAP3K13 | 1.55060809 |
| 22 | FGR | 1.49982413 |
| 23 | CSK | 1.46018563 |
| 24 | YES1 | 1.37817378 |
| 25 | FGFR3 | 1.36691103 |
| 26 | MAP3K11 | 1.36321233 |
| 27 | HCK | 1.32428872 |
| 28 | BMPR2 | 1.32188177 |
| 29 | MAP3K3 | 1.27602497 |
| 30 | MAP3K1 | 1.24692094 |
| 31 | MARK3 | 1.24040313 |
| 32 | SYK | 1.17565297 |
| 33 | ERBB3 | 1.16692405 |
| 34 | TAOK2 | 1.14582476 |
| 35 | BTK | 1.14409698 |
| 36 | CSF1R | 1.10882250 |
| 37 | KSR2 | 1.06687105 |
| 38 | TEC | 1.05463297 |
| 39 | ERN1 | 1.05031265 |
| 40 | LYN | 1.01913519 |
| 41 | TRPM7 | 1.01178532 |
| 42 | PIM1 | 1.01076685 |
| 43 | FES | 1.00764118 |
| 44 | TAOK3 | 0.99612682 |
| 45 | TGFBR2 | 0.97481246 |
| 46 | LCK | 0.96547366 |
| 47 | CLK1 | 0.96103490 |
| 48 | ZAP70 | 0.95756610 |
| 49 | NUAK1 | 0.94492875 |
| 50 | CDC42BPA | 0.90974320 |
| 51 | STK24 | 0.86006206 |
| 52 | PDK1 | 0.82283101 |
| 53 | IRAK1 | 0.81968888 |
| 54 | EPHB1 | 0.81852272 |
| 55 | SIK2 | 0.80343768 |
| 56 | MARK2 | 0.79557374 |
| 57 | JAK2 | 0.78430143 |
| 58 | RPS6KA4 | 0.77399284 |
| 59 | MATK | 0.76821825 |
| 60 | MAP2K3 | 0.75075384 |
| 61 | PIM2 | 0.72945574 |
| 62 | FGFR4 | 0.72664380 |
| 63 | EPHA3 | 0.71412614 |
| 64 | PBK | 0.70316299 |
| 65 | MAP3K6 | 0.69984507 |
| 66 | PDPK1 | 0.69765209 |
| 67 | BMPR1B | 0.69592607 |
| 68 | CASK | 0.66055974 |
| 69 | SGK2 | 0.65615110 |
| 70 | MOS | 0.65413653 |
| 71 | IRAK2 | 0.65095575 |
| 72 | MAP3K5 | 0.64357894 |
| 73 | TRIB3 | 0.63476072 |
| 74 | STK10 | 0.62974632 |
| 75 | ABL1 | 0.62275421 |
| 76 | PRKCD | 0.61449472 |
| 77 | PRKD2 | 0.60698939 |
| 78 | RIPK1 | 0.59026654 |
| 79 | HIPK2 | 0.58028204 |
| 80 | TIE1 | 0.57128141 |
| 81 | FYN | 0.57079378 |
| 82 | MAPK12 | 0.55161810 |
| 83 | PIK3CG | 0.54365375 |
| 84 | SGK3 | 0.54172397 |
| 85 | ADRBK2 | 0.53355413 |
| 86 | PLK4 | 0.52222784 |
| 87 | MAP3K2 | 0.51982887 |
| 88 | LRRK2 | 0.51859910 |
| 89 | SMG1 | 0.51435742 |
| 90 | TNK2 | 0.50106180 |
| 91 | SIK1 | 0.48723472 |
| 92 | PRKCQ | 0.48352426 |
| 93 | STK3 | 0.48310369 |
| 94 | CDK19 | 0.47883810 |
| 95 | MAP3K7 | 0.47724486 |
| 96 | EGFR | 0.45171776 |
| 97 | RPS6KA6 | 0.43898668 |
| 98 | TESK2 | 0.42949836 |
| 99 | PRKG2 | 0.42812421 |
| 100 | CDK12 | 0.42722074 |
| 101 | ERBB4 | 0.42122437 |
| 102 | BMX | 0.41522931 |
| 103 | INSRR | 0.40421555 |
| 104 | PTK6 | 0.39382689 |
| 105 | MAPKAPK2 | 0.36653779 |
| 106 | PTK2B | 0.36411778 |
| 107 | RPS6KA2 | 0.36284574 |
| 108 | STK4 | 0.35735292 |
| 109 | ITK | 0.34997525 |
| 110 | RPS6KC1 | 0.34118210 |
| 111 | RPS6KL1 | 0.34118210 |
| 112 | DYRK1B | 0.33394099 |
| 113 | PRKAA2 | 0.32941374 |
| 114 | CDK6 | 0.32653395 |
| 115 | MAP2K6 | 0.31992088 |
| 116 | GRK7 | 0.31481271 |
| 117 | KSR1 | 0.31112984 |
| 118 | SGK1 | 0.30762647 |
| 119 | PKN1 | 0.29497562 |
| 120 | STK11 | 0.29177120 |
| 121 | RET | 0.29013164 |
| 122 | PRPF4B | 0.28675421 |
| 123 | RAF1 | 0.28209402 |
| 124 | BRD4 | 0.27952750 |
| 125 | DAPK2 | 0.27564995 |
| 126 | NLK | 0.26360457 |
| 127 | NEK9 | 0.26118180 |
| 128 | PLK2 | 0.25245990 |
| 129 | MAPK7 | 0.23356872 |
| 130 | MUSK | 0.22656645 |
| 131 | CDK8 | 0.21502574 |
| 132 | GRK1 | 0.21181990 |
| 133 | INSR | 0.19206339 |
| 134 | IGF1R | 0.18271995 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Leishmaniasis_Homo sapiens_hsa05140 | 3.18170353 |
| 2 | NF-kappa B signaling pathway_Homo sapiens_hsa04064 | 2.92821418 |
| 3 | Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 2.74916902 |
| 4 | Graft-versus-host disease_Homo sapiens_hsa05332 | 2.54266579 |
| 5 | Cytosolic DNA-sensing pathway_Homo sapiens_hsa04623 | 2.43147625 |
| 6 | Osteoclast differentiation_Homo sapiens_hsa04380 | 2.35946657 |
| 7 | Legionellosis_Homo sapiens_hsa05134 | 2.31714125 |
| 8 | * NOD-like receptor signaling pathway_Homo sapiens_hsa04621 | 2.31321536 |
| 9 | Malaria_Homo sapiens_hsa05144 | 2.30714975 |
| 10 | Measles_Homo sapiens_hsa05162 | 2.30447308 |
| 11 | RIG-I-like receptor signaling pathway_Homo sapiens_hsa04622 | 2.24945321 |
| 12 | Allograft rejection_Homo sapiens_hsa05330 | 2.19321302 |
| 13 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 2.09895015 |
| 14 | Influenza A_Homo sapiens_hsa05164 | 2.09132779 |
| 15 | * Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | 2.07329615 |
| 16 | * TNF signaling pathway_Homo sapiens_hsa04668 | 2.07235928 |
| 17 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 2.03627168 |
| 18 | * Tuberculosis_Homo sapiens_hsa05152 | 2.00442941 |
| 19 | Pertussis_Homo sapiens_hsa05133 | 1.98623375 |
| 20 | Hematopoietic cell lineage_Homo sapiens_hsa04640 | 1.86357730 |
| 21 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 1.82632453 |
| 22 | Asthma_Homo sapiens_hsa05310 | 1.81179184 |
| 23 | Herpes simplex infection_Homo sapiens_hsa05168 | 1.77179586 |
| 24 | B cell receptor signaling pathway_Homo sapiens_hsa04662 | 1.67231848 |
| 25 | African trypanosomiasis_Homo sapiens_hsa05143 | 1.63825073 |
| 26 | Toxoplasmosis_Homo sapiens_hsa05145 | 1.60021084 |
| 27 | Cytokine-cytokine receptor interaction_Homo sapiens_hsa04060 | 1.45428154 |
| 28 | Apoptosis_Homo sapiens_hsa04210 | 1.44701491 |
| 29 | Jak-STAT signaling pathway_Homo sapiens_hsa04630 | 1.40503326 |
| 30 | Salmonella infection_Homo sapiens_hsa05132 | 1.39349173 |
| 31 | Natural killer cell mediated cytotoxicity_Homo sapiens_hsa04650 | 1.36281840 |
| 32 | Hepatitis C_Homo sapiens_hsa05160 | 1.35650739 |
| 33 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 1.35643138 |
| 34 | Phagosome_Homo sapiens_hsa04145 | 1.35068982 |
| 35 | Autoimmune thyroid disease_Homo sapiens_hsa05320 | 1.30172212 |
| 36 | Chagas disease (American trypanosomiasis)_Homo sapiens_hsa05142 | 1.28832930 |
| 37 | Chemokine signaling pathway_Homo sapiens_hsa04062 | 1.26394974 |
| 38 | Lysosome_Homo sapiens_hsa04142 | 1.20050700 |
| 39 | Primary immunodeficiency_Homo sapiens_hsa05340 | 1.19732439 |
| 40 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 1.19113392 |
| 41 | Fc gamma R-mediated phagocytosis_Homo sapiens_hsa04666 | 1.18112538 |
| 42 | Hepatitis B_Homo sapiens_hsa05161 | 1.17071836 |
| 43 | AGE-RAGE signaling pathway in diabetic complications_Homo sapiens_hsa04933 | 1.06598041 |
| 44 | * Shigellosis_Homo sapiens_hsa05131 | 1.04993577 |
| 45 | T cell receptor signaling pathway_Homo sapiens_hsa04660 | 0.99943146 |
| 46 | Other glycan degradation_Homo sapiens_hsa00511 | 0.99215004 |
| 47 | Fc epsilon RI signaling pathway_Homo sapiens_hsa04664 | 0.96434934 |
| 48 | Epithelial cell signaling in Helicobacter pylori infection_Homo sapiens_hsa05120 | 0.94861660 |
| 49 | Non-small cell lung cancer_Homo sapiens_hsa05223 | 0.91815395 |
| 50 | Amoebiasis_Homo sapiens_hsa05146 | 0.90680541 |
| 51 | Leukocyte transendothelial migration_Homo sapiens_hsa04670 | 0.87599360 |
| 52 | VEGF signaling pathway_Homo sapiens_hsa04370 | 0.84399229 |
| 53 | Notch signaling pathway_Homo sapiens_hsa04330 | 0.82999316 |
| 54 | Glycosaminoglycan biosynthesis - chondroitin sulfate / dermatan sulfate_Homo sapiens_hsa00532 | 0.82468657 |
| 55 | Viral myocarditis_Homo sapiens_hsa05416 | 0.80202568 |
| 56 | Acute myeloid leukemia_Homo sapiens_hsa05221 | 0.80149601 |
| 57 | Antigen processing and presentation_Homo sapiens_hsa04612 | 0.79162964 |
| 58 | Prolactin signaling pathway_Homo sapiens_hsa04917 | 0.74456734 |
| 59 | Transcriptional misregulation in cancer_Homo sapiens_hsa05202 | 0.72389113 |
| 60 | Small cell lung cancer_Homo sapiens_hsa05222 | 0.71661079 |
| 61 | Renal cell carcinoma_Homo sapiens_hsa05211 | 0.70989404 |
| 62 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 0.70221120 |
| 63 | Pancreatic cancer_Homo sapiens_hsa05212 | 0.67399555 |
| 64 | Epstein-Barr virus infection_Homo sapiens_hsa05169 | 0.67226170 |
| 65 | Sphingolipid metabolism_Homo sapiens_hsa00600 | 0.66327771 |
| 66 | Chronic myeloid leukemia_Homo sapiens_hsa05220 | 0.63948667 |
| 67 | Type II diabetes mellitus_Homo sapiens_hsa04930 | 0.62943790 |
| 68 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 0.61386877 |
| 69 | SNARE interactions in vesicular transport_Homo sapiens_hsa04130 | 0.60749575 |
| 70 | Neurotrophin signaling pathway_Homo sapiens_hsa04722 | 0.59797880 |
| 71 | Endocytosis_Homo sapiens_hsa04144 | 0.57037022 |
| 72 | GnRH signaling pathway_Homo sapiens_hsa04912 | 0.56517662 |
| 73 | Pathogenic Escherichia coli infection_Homo sapiens_hsa05130 | 0.56429215 |
| 74 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 0.56203752 |
| 75 | Phospholipase D signaling pathway_Homo sapiens_hsa04072 | 0.54988506 |
| 76 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | 0.47901420 |
| 77 | Platelet activation_Homo sapiens_hsa04611 | 0.47443606 |
| 78 | p53 signaling pathway_Homo sapiens_hsa04115 | 0.47228005 |
| 79 | HTLV-I infection_Homo sapiens_hsa05166 | 0.46948424 |
| 80 | Cell adhesion molecules (CAMs)_Homo sapiens_hsa04514 | 0.46030278 |
| 81 | MicroRNAs in cancer_Homo sapiens_hsa05206 | 0.45462669 |
| 82 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.45158293 |
| 83 | Bacterial invasion of epithelial cells_Homo sapiens_hsa05100 | 0.45057287 |
| 84 | Choline metabolism in cancer_Homo sapiens_hsa05231 | 0.44033935 |
| 85 | Endometrial cancer_Homo sapiens_hsa05213 | 0.43538225 |
| 86 | Caffeine metabolism_Homo sapiens_hsa00232 | 0.43490971 |
| 87 | Regulation of actin cytoskeleton_Homo sapiens_hsa04810 | 0.42577917 |
| 88 | Sphingolipid signaling pathway_Homo sapiens_hsa04071 | 0.42456977 |
| 89 | Amyotrophic lateral sclerosis (ALS)_Homo sapiens_hsa05014 | 0.42018192 |
| 90 | Bladder cancer_Homo sapiens_hsa05219 | 0.41794578 |
| 91 | Viral carcinogenesis_Homo sapiens_hsa05203 | 0.41717993 |
| 92 | Inositol phosphate metabolism_Homo sapiens_hsa00562 | 0.40423169 |
| 93 | mTOR signaling pathway_Homo sapiens_hsa04150 | 0.35571196 |
| 94 | Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | 0.35550191 |
| 95 | Dorso-ventral axis formation_Homo sapiens_hsa04320 | 0.35523195 |
| 96 | HIF-1 signaling pathway_Homo sapiens_hsa04066 | 0.35015067 |
| 97 | Collecting duct acid secretion_Homo sapiens_hsa04966 | 0.35012083 |
| 98 | Proteoglycans in cancer_Homo sapiens_hsa05205 | 0.34964415 |
| 99 | FoxO signaling pathway_Homo sapiens_hsa04068 | 0.34727771 |
| 100 | Systemic lupus erythematosus_Homo sapiens_hsa05322 | 0.34142385 |
| 101 | Arachidonic acid metabolism_Homo sapiens_hsa00590 | 0.34106122 |
| 102 | ErbB signaling pathway_Homo sapiens_hsa04012 | 0.33313193 |
| 103 | Phosphatidylinositol signaling system_Homo sapiens_hsa04070 | 0.33266544 |
| 104 | Colorectal cancer_Homo sapiens_hsa05210 | 0.32863298 |
| 105 | MAPK signaling pathway_Homo sapiens_hsa04010 | 0.31600436 |
| 106 | Vitamin digestion and absorption_Homo sapiens_hsa04977 | 0.31251103 |
| 107 | Inflammatory mediator regulation of TRP channels_Homo sapiens_hsa04750 | 0.27096467 |
| 108 | Estrogen signaling pathway_Homo sapiens_hsa04915 | 0.26204468 |
| 109 | Mucin type O-Glycan biosynthesis_Homo sapiens_hsa00512 | 0.24709371 |
| 110 | Insulin resistance_Homo sapiens_hsa04931 | 0.22099947 |
| 111 | Adherens junction_Homo sapiens_hsa04520 | 0.21911205 |
| 112 | Mineral absorption_Homo sapiens_hsa04978 | 0.21445215 |
| 113 | Pathways in cancer_Homo sapiens_hsa05200 | 0.21116195 |
| 114 | ABC transporters_Homo sapiens_hsa02010 | 0.20794367 |
| 115 | Rap1 signaling pathway_Homo sapiens_hsa04015 | 0.19461492 |
| 116 | Prostate cancer_Homo sapiens_hsa05215 | 0.19004070 |

